- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03865823
Evaluation of the Recovery Rate and Postoperative Incontinence of Surgical Fistulas in a Cohort of a Reference Centre (PROFIL)
Fistula is a pathology that can be complex and lead to treatment difficulties for the proctologist.
The proctologist's objective is to treat the infection (anal fistula and abscess) with the minimum impact on anal continence. Drainage of the fistula pathway(s) and removal of infected tissue during initial surgery are essential. The treatment of upper trans-sphincterial fistulas, i. e. those that span more than half the height of the anal sphincter, poses risks to anal continence. It sometimes requires several times of surgical treatment.
The study aim to investigate the fate of all patients treated for anal fistula in an expert team, in terms of impact on healing and anal continence and according to the type of anal fistula, the co-morbidity, the surgical techniques used and the bacterial flora responsible.
Study Overview
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Elsa LAMBRESCAK, MD
- Phone Number: +33 1 44 64 20 45
- Email: elambrescak@hopital-dcss.org
Study Locations
-
-
-
Paris, France, 75020
- Recruiting
- Groupe Hospitalier Diaconesses Croix Saint Simon
-
Contact:
- Elsa LAMBRESCAK, MD
- Email: elambrescak@hopital-dcss.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient over the age of 18, patient with an anus fistula with indication for surgical treatment
Exclusion Criteria:
- Cutaneous Suppuration, without fistula (e.g., Verneuil disease, boil)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
anal Fistula
patient with anal fistula with indication to surgical treatment
|
A pus sample from the fistula will be taken by the doctor during this first consultation or, failing that, in the operating room before disinfection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identify the risk factors, including infectious, of failure of the surgery of the fistula in an expert center
Time Frame: 2 years
|
2 year recovery rate after initial surgery of anal fistula
|
2 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D_ELK_2018_2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anal Fistula
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
Societa Italiana di Chirurgia ColoRettaleTerminated
-
Mansoura UniversityUnknownVideo Assisted Anal Fistula TreatmentEgypt
-
F Care Systems NVNot yet recruiting
-
Groupe Hospitalier Paris Saint JosephCompletedComplex Anal FistulaFrance
-
Assiut UniversityActive, not recruiting
-
University Hospital, Clermont-FerrandUnknown
-
Dr Benjamin NEBBOTSuspended
-
University of Southern DenmarkOdense University HospitalCompleted
-
Chinese University of Hong KongTerminated
Clinical Trials on pus sample
-
Institut PasteurInstitut Pasteur de BanguiActive, not recruitingMonkeypox Virus InfectionCentral African Republic
-
Chulalongkorn UniversityUnknownDisorder of Skin Donor SiteThailand
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingNarcolepsy Type 1 | Bacterial TranslocationFrance
-
The First Affiliated Hospital of Soochow UniversityRecruitingGraft Vs Host DiseaseChina
-
University Hospital of Girona Dr.Josep TruetaGirona Biomedical Research InstituteRecruiting
-
University Hospital, BrestRecruitingSystemic Lupus Erythematosus (SLE)France
-
First Affiliated Hospital of Zhejiang UniversityRecruitingComplication | Hematologic Malignancy | Hematopoietic Stem Cell Transplantation | Chronic Graft-versus-host-diseaseChina
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruitingImmune Thrombocytopenia | Autoimmune Hemolytic Anemia | Autoimmune NeutropeniaFrance
-
University Hospital, ToursCompletedMetastatic Prostate Cancer | Circulating Tumor DNAFrance